CDMO  valuation analysis

Name: Avid Bioservices Inc
Description: Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 08, 2022
Market cap: $1.37B (1195th)
Sales(TTM): $115.98M (1402nd)
Earnings(TTM): $14.06M (1214th)

FFER: 1.17 (why)
Actual price: $21.50
FFEThis is Avid Bioservices Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $18.42
Quantile: CDMO is expensive given its fundamentals.
Prices as of EOD 2022-03-17
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Avid Bioservices Inc
"Biotechnology" industry
Sales / MarketCap
Avid Bioservices Inc
"Biotechnology" industry
Book / MarketCap
Avid Bioservices Inc
"Biotechnology" industry
Equity / Assets
Avid Bioservices Inc
"Biotechnology" industry